AU3605100A - Antigen to systemic lupus erythematosis and diagnostic assay - Google Patents

Antigen to systemic lupus erythematosis and diagnostic assay

Info

Publication number
AU3605100A
AU3605100A AU36051/00A AU3605100A AU3605100A AU 3605100 A AU3605100 A AU 3605100A AU 36051/00 A AU36051/00 A AU 36051/00A AU 3605100 A AU3605100 A AU 3605100A AU 3605100 A AU3605100 A AU 3605100A
Authority
AU
Australia
Prior art keywords
antigen
systemic lupus
diagnostic assay
lupus erythematosis
erythematosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36051/00A
Inventor
Tai June Yoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3605100A publication Critical patent/AU3605100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU36051/00A 1999-02-25 2000-02-25 Antigen to systemic lupus erythematosis and diagnostic assay Abandoned AU3605100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12154799P 1999-02-25 1999-02-25
US60121547 1999-02-25
PCT/US2000/004770 WO2000050455A2 (en) 1999-02-25 2000-02-25 Antigen to systemic lupus erythematosis and diagnostic assay

Publications (1)

Publication Number Publication Date
AU3605100A true AU3605100A (en) 2000-09-14

Family

ID=22397407

Family Applications (2)

Application Number Title Priority Date Filing Date
AU36053/00A Abandoned AU3605300A (en) 1999-02-25 2000-02-25 Vaccine for house dust mite allergen using naked plasmid dna
AU36051/00A Abandoned AU3605100A (en) 1999-02-25 2000-02-25 Antigen to systemic lupus erythematosis and diagnostic assay

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU36053/00A Abandoned AU3605300A (en) 1999-02-25 2000-02-25 Vaccine for house dust mite allergen using naked plasmid dna

Country Status (6)

Country Link
US (2) US7439233B1 (en)
EP (1) EP1162983A1 (en)
KR (1) KR20020000218A (en)
AU (2) AU3605300A (en)
CA (1) CA2362928A1 (en)
WO (2) WO2000050044A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0006437D0 (en) 2000-03-17 2000-05-10 Leuven Res & Dev Vzw Compounds for the modulation of allergen sensitivity by antigens sharing T cell epitopes with allergens
US6773695B2 (en) * 2000-10-05 2004-08-10 Mannkind Corporation Modulation of allergic response
FR2822709B1 (en) * 2001-03-30 2007-01-19 Antialis ANTI-ALLERGIC PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE ALLERGEN AND AT LEAST ONE ANTIHISTAMINE COMPOUND
AU2003256240A1 (en) * 2002-08-29 2004-03-19 National University Of Singapore Recombinant nucleic acid useful for inducing protective immune response against allergens
CN101318017B (en) * 2007-06-05 2013-04-10 中国农业大学 Vaccine for preventing and/or treating allergic asthma
NL2014882B1 (en) * 2015-05-29 2017-01-31 Citeq B V Allergy-specific immunotherapy compositions for use in the treatment of house-dust mite allergy.
EP3569612A1 (en) 2018-05-18 2019-11-20 Biomay Ag Treatment and prevention of house dust mite allergies
WO2020046217A1 (en) * 2018-08-28 2020-03-05 Chulalongkorn University A nucleic acid construct for inhibiting the house dust mite allergic response

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570439B2 (en) * 1983-03-28 1988-03-17 Compression Labs, Inc. A combined intraframe and interframe transform coding system
US6147201A (en) * 1987-06-17 2000-11-14 Immulogic Pharmaceutical Corporation Cloning and sequencing of allergens of dermatophagoides (house dust mite)
EP0460076B1 (en) * 1989-02-24 1995-11-29 The Regents Of The University Of California Genetically engineered immunoglobulins
US7288256B1 (en) * 1991-10-16 2007-10-30 Merck Patent Gmbh T cell epitopes of the major allergens from dermatophagoides (house dust mite)
WO1994024281A1 (en) * 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
US6849427B1 (en) * 1993-03-12 2005-02-01 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor
US6180771B1 (en) * 1993-12-08 2001-01-30 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor
US6121247A (en) 1996-03-29 2000-09-19 The Johns Hopkins University Therapy for allergic diseases
TW480282B (en) * 1996-04-24 2002-03-21 Ren Wen Corp Recombinant eucaryotic vector containing allergen gene and use of preventing and treating allergic disease thereof
AU5587998A (en) * 1996-11-15 1998-06-03 Cornell Research Foundation Inc. Activated ras interaction assay
US5885783A (en) * 1997-07-02 1999-03-23 Yoo; Tai-June Autoimmune inner ear disease antigen and diagnostic assay
US6266491B1 (en) * 1999-10-05 2001-07-24 Eastman Kodak Company Camera frame assembly having standby battery station

Also Published As

Publication number Publication date
WO2000050455A3 (en) 2001-02-08
AU3605300A (en) 2000-09-14
WO2000050044A1 (en) 2000-08-31
EP1162983A1 (en) 2001-12-19
US7439233B1 (en) 2008-10-21
WO2000050455A2 (en) 2000-08-31
US20090104213A1 (en) 2009-04-23
KR20020000218A (en) 2002-01-05
CA2362928A1 (en) 2000-08-31

Similar Documents

Publication Publication Date Title
AUPR005600A0 (en) Diagnostic assay
AU7398200A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU3440900A (en) Assay system
AU777123C (en) Chemiluminescent assay
AU3159499A (en) Antigen preparation and use
AU7039400A (en) Solid soap with connecting and keeping means
AU3605100A (en) Antigen to systemic lupus erythematosis and diagnostic assay
AU2841801A (en) Triazolotriazinones and the use thereof
AU1569299A (en) Sample-collecting and assay device
AU2138501A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
GB0009213D0 (en) Improved assay analysis
AU4149800A (en) Hand and pedal driving device
AU6491699A (en) Biosensor cell device and its use
AU4586700A (en) Improved assay and reagents therefor
AU2138601A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU1531801A (en) Novel assay
AU6835300A (en) Diagnostic kit and use thereof
GB0402680D0 (en) Improved assay analysis
AU7537400A (en) Assay
AU6601098A (en) Vaccine and assay
AU2813700A (en) Protein assay
AU1269801A (en) Endogenous gene expression assay
AU1375501A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU1023901A (en) Electrochemical enzyme immuno assay
AU7302200A (en) Assay

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase